Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers. Dr. Lynch sets the strategic direction of the center, oversees centerwide initiatives and represents the Hutch’s interests to major partners and governmental bodies. He also directs the Fred Hutch/University of Washington Cancer Consortium and is principal investigator of its Cancer Center Support Grant.
Read more about Dr. Lynch.
Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
Fred Hutch President and Director Dr. Tom Lynch shares partnerships in 2021 that fueled important new scientific strides — and what we see in 2022.
Take a look behind the scenes in the Kugel Lab at Fred Hutch, where researchers are exploring new ways to treat an aggressive subtype of pancreatic cancer.
Take a look behind the scenes of the Chapuis Lab at Fred Hutch.
President & Director and holder of the Raisbeck Endowed Chair Dr. Tom Lynch visits the lab of Dr. Meghan Koch in Fred Hutch's Basic Sciences Division, where researchers looks to answer fundamental questions about the development of the immune system.
Fred Hutch Director and President Dr. Thomas Lynch Jr. visits the Newell Lab to see how immunotherapy research and data science come together in the Steam Plant.
Fred Hutch President & Director Dr. Thomas J. Lynch Jr. visits the Berger Lab to meet the staff and see what the lab is working on.
The Fred Hutchinson Cancer Center opening day event on April 1, 2022, featuring remarks from Fred Hutch President and Director Dr. Thomas J. Lynch Jr., board chair Kathy Surace-Smith, UW Medicine CEO Dr. Paul Ramsey, Fred Hutch Executive Vice President and Deputy Director Dr. Bruce Clurman, and Fred Hutch Chief Nursing Officer Dr. Terry McDonnell.
Fred Hutch President and Director Dr. Tom Lynch shares partnerships in 2021 that fueled important new scientific strides — and what we see in 2022.
Dr. Tom Lynch spoke with Drs. Alice Berger, Lucas Sullivan and Christopher Li at Fred Hutch's Science Says virtual event on May 25, 2022, about how emerging technologies and a growing volume and variety of molecular data are allowing scientists to create personalized cancer therapies and prevention strategies.
Dr. Tom Lynch tours the Emerman Lab with Dr. Emerman — learns more hear about the efforts to find insights into effective cellular antiviral defenses could also shed light on avenues for development of potential future antiretroviral therapies for HIV and COVID.
Seattle Magazine featured Fred Hutch scientists Drs. Phil Greenberg, Denise Galloway, E. Gabriela Chiorean and Petros Grivas in an article about doctors who continue to make Seattle a hotbed of cancer research and treatment.
Dr. Liz Duke explained a study of antivirals to prevent COVID.
Drs. Tom Lynch and Paul Ramsey describe unified adult cancer care.
Dr. Tom Lynch spoke about Fred Hutch’s growing catchment area and how to serve populations across WA state.
Drs. Paul Ramsey and Tom Lynch discuss the cancer care restructure.
Dr. Tom Lynch joined Seattle Cancer Care Alliance, UW Medicine and Seattle Children’s leaders in describing how the new structure will expedite new therapies.
Dr. Tom Lynch described how the restructure of Fred Hutch, UW Medicine, Seattle Children's, and Seattle Cancer Care Alliance could improve startups.
Dr. Thomas Lynch described the gratification of improving lung cancer death rates in the US.
Dr. Thomas Lynch described why he’s excited about the opening of the Lake Union Steam Plant.
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
Fred Hutch President and Director Dr. Tom Lynch spoke with Fierce Biotech about his new role, the Hutch’s scientific priorities and COVID-19.
President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs.
President Dr. Thomas Lynch explained the work Fred Hutch is doing on COVID-19 research and vaccines.
Dr. Thomas Lynch and his live virtual chat with GeekWire are highlighted.
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
Dr. Tom Lynch commented on the hard work and early data from the SCAN COVID-19 testing program.
Dr. Tom Lynch described the challenges of testing and accurately reporting COVID-19 in a Fred Hutch town hall.